Sigyn Therapeutics, Inc.
SIGY
$4.10
-$0.0099-0.24%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.20M | -862.40K | -758.10K | -1.18M | -905.70K |
| Total Depreciation and Amortization | 1.40K | 1.40K | 1.50K | 3.70K | -100.00 |
| Total Amortization of Deferred Charges | 362.80K | 259.00K | 126.60K | 582.60K | 266.90K |
| Total Other Non-Cash Items | 292.50K | 37.50K | 37.50K | -23.00K | 34.90K |
| Change in Net Operating Assets | 376.40K | 381.70K | 356.80K | 484.80K | 239.90K |
| Cash from Operations | -163.80K | -182.80K | -235.60K | -127.90K | -364.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 301.50K | 228.60K | 276.80K | 75.00K | 405.00K |
| Total Debt Repaid | -26.60K | -25.00K | -20.00K | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 275.00K | 203.60K | 256.80K | 75.00K | 405.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.10K | 20.80K | 21.10K | -52.90K | 41.00K |
